| Items | Drug Registration information |
|---|---|
| ID | 1641 |
| No | 1641 |
| Brand Name | CABOZAN 20 MG |
| Ingredients | CABOZANTINIB 20 MG |
| Dosage Form | CAPSULE |
| Primary Packaging | BOTTLE |
| Storage | |
| Shelf Life | 2 YEARS |
| Pack Size | 90 TABLETS/BOTTLE |
| Dispensing Category | |
| ATC Classification | |
| Pharmaceutical Class | |
| Indications | FOR TREATMENT OF PATIENTS WITH PROGRESSIVE, METASTATIC MEDULLARY THYROID CANCER, RENAL CELL CARCINOMA AND HEPATOCELLULAR CARCINOMA. |
| Contraindications | |
| Side Effects | |
| Unit Price | |
| EDL | NULL |
| Description | RED CAPSULE |
| Note | |
| License Owner | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
| Manufacturer | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
| Country | LAOS |
| Import Registration No | |
| Import Registration Date | |
| Activity | CERTIFICATE RELEASED |
| Applied Date | |
| FDD Registration No | 03 L 0957/23 |
| FDD Registration Date | 31/03/2025 |
| Expiry Date | 30/03/2030 |